share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gibson Christopher

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gibson Christopher

Recursion Pharmaceuticals | 4:持股变动声明-高管 Gibson Christopher
美股SEC公告 ·  08/09 16:58
Moomoo AI 已提取核心信息
Recursion Pharmaceuticals, Inc. CEO Christopher Gibson completed a sale of company stock over two days, on August 7 and August 8, 2024. Gibson sold a total of 50,000 shares of Class A Common Stock in open market transactions. On the first day, 30,000 shares were sold at a price of $7.10 per share, followed by 20,000 shares at $6.50 per share the next day. The total market value of the disposed shares amounted to $343,000. Following these transactions, Gibson directly holds 758,738 shares of Recursion Pharmaceuticals.
Recursion Pharmaceuticals, Inc. CEO Christopher Gibson completed a sale of company stock over two days, on August 7 and August 8, 2024. Gibson sold a total of 50,000 shares of Class A Common Stock in open market transactions. On the first day, 30,000 shares were sold at a price of $7.10 per share, followed by 20,000 shares at $6.50 per share the next day. The total market value of the disposed shares amounted to $343,000. Following these transactions, Gibson directly holds 758,738 shares of Recursion Pharmaceuticals.
Recursion Pharmaceuticals,Inc.董事长克里斯托弗·吉布森(Christopher Gibson)于2024年8月7日和8日连续两天完成了公司股票的出售。 吉布森在公开市场交易中共出售了50,000股A类普通股。第一天卖出30,000股,每股价格为7.10美元,第二天卖出20,000股,每股价格为6.50美元。已抛售股份的总市值为343,000美元。在此交易之后,吉布森直接持有Recursion Pharmaceuticals的758,738股股份。
Recursion Pharmaceuticals,Inc.董事长克里斯托弗·吉布森(Christopher Gibson)于2024年8月7日和8日连续两天完成了公司股票的出售。 吉布森在公开市场交易中共出售了50,000股A类普通股。第一天卖出30,000股,每股价格为7.10美元,第二天卖出20,000股,每股价格为6.50美元。已抛售股份的总市值为343,000美元。在此交易之后,吉布森直接持有Recursion Pharmaceuticals的758,738股股份。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息